Trials / Completed
CompletedNCT01006941
Trichuris Suis Ova Therapy for Relapsing Multiple Sclerosis - a Safety Study
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Rigshospitalet, Denmark · Academic / Other
- Sex
- All
- Age
- 19 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
The hypothesis of this study is that treatment with Trichuris suis ova will be safe and effective as an oral treatment of patients with relapsing multiple sclerosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Trichuris suis ova | 2500 ova per dose, orally, every second week, during 12 weeks |
Timeline
- Start date
- 2010-05-01
- Primary completion
- 2011-01-01
- Completion
- 2011-09-01
- First posted
- 2009-11-03
- Last updated
- 2011-11-10
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT01006941. Inclusion in this directory is not an endorsement.